MediFind
Condition

Small Cell Lung Cancer

Latest Research

Latest Advance
Study
  • Condition: COVID-19
  • Journal: Seminars in oncology
  • Treatment Used: RRx-001
  • Published —
This article summarizes the potential ability for RRx-001 to attenuate the respiratory effects of COVID-19.
Latest Advance
Study
  • Condition: Non-Small Cell Lung Cancer (NSCLC)
  • Journal: Current treatment options in oncology
  • Treatment Used: Immunotherapy Alone or in Combination with Chemotherapy as First-Line Treatment
  • Published —
This article discusses immunotherapy alone or in combination with chemotherapy as first-line treatment for patients with non-small cell lung cancer (NSCLC).
Latest Advance
Study
  • Condition: Metastatic Small Cell Lung Cancer/Chronic Obstructive Pulmonary Disease/Intractable Cough
  • Journal: BMJ supportive & palliative care
  • Treatment Used: Fan Therapy
  • Number of Patients: 1
  • Published —
This study investigated fan therapy in the treatment of a woman with metastatic small cell lung cancer (disease in which cells in the lung begin growing out of control) and chronic obstructive pulmonary disease (chronic inflammatory lung disease that causes obstructed airflow from the lungs) with an intractable cough (difficult to control cough).
Latest Advance
Study
  • Condition: Neuroendocrine Tumors (NETs) of Lung
  • Journal: Journal for immunotherapy of cancer
  • Treatment Used: Lutathera
  • Number of Patients: 9
  • Published —
This study evaluated lutathera plus nivolumab in patients with advanced neuroendocrine tumors (NETs) of the lung.
Latest Advance
Study
  • Condition: Small Cell Lung Cancer and Large Cell Neuroendocrine Carcinoma
  • Journal: Lung cancer (Amsterdam, Netherlands)
  • Treatment Used: SC-002
  • Number of Patients: 35
  • Published —
The study researched the effects of SC-002 in patients with relapsed or refractory small cell lung cancer and large cell neuroendocrine carcinoma.
Latest Advance
Study
  • Condition: Non-Small Cell Lung Cancer (NSCLC) with Complex Epidermal Growth Factor (EGFR) Mutations and Secondary T790M Mutation
  • Journal: Lung cancer (Amsterdam, Netherlands)
  • Treatment Used: Osimertinib
  • Number of Patients: 165
  • Published —
This study considered patients with non-small cell lung cancer (NSCLC) who have complex epidermal growth factor (EGFR) mutations and secondary T790M mutation in order to analyze the safety and effectiveness of osimertinib as a treatement.
Latest Advance
Study
  • Condition: Recurrent Small Cell Lung Cancer
  • Journal: British journal of cancer
  • Treatment Used: 130-Nm Albumin-Bound Paclitaxel
  • Number of Patients: 68
  • Published —
The study researched the use of NAB-paclitaxel in treating small cell lung cancer.
Latest Advance
Study
  • Condition: Patients With Limited-Stage Small Cell Lung Cancer (SCLC)
  • Journal: JAMA network open
  • Treatment Used: With and Without Prophylactic Cranial Irradiation (PCI)
  • Number of Patients: 297
  • Published —
This study reported the overall survival and rates of intracranial control for patients with limited stage-small cell lung cancer (LS-SCLC), all staged with MRI, who either did or did not undergo prophylactic cranial irradiation (PCI).
Latest Advance
Study
  • Condition: Small-cell Lung Cancer
  • Journal: Clinical lung cancer
  • Treatment Used: Carfilzomib Plus Irinotecan
  • Number of Patients: 62
  • Published —
The study researched the safety and effectiveness of Carfilzomib plus Irinotecan in patients with small-cell lung cancer.
Latest Advance
Study
  • Condition: Limited Disease Small Cell Lung Cancer
  • Journal: International journal of radiation oncology, biology, physics
  • Treatment Used: Cranial Irradiation with Hippocampal Avoidance
  • Number of Patients: 44
  • Published —
The study researched the outcomes of cranial irradiation with hippocampal avoidance on brain function in patients with limited disease small cell lung cancer.
Latest Advance
Study
  • Condition: Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
  • Journal: Current oncology reports
  • Treatment Used: First-line Treatment
  • Published —
This article reviews updated standards of care for patients with extensive-stage small cell lung cancer (ES-SCLC).
Latest Advance
Study
  • Condition: Limited-stage small cell lung cancer
  • Journal: World journal of surgical oncology
  • Treatment Used: Comprehensive treatment including radical resection
  • Number of Patients: 152
  • Published —
The study researched the effects of comprehensive treatment including radical resection on limited-stage small cell lung cancer.